Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
Federal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices
The Federal Trade Commission took action Friday against the nation’s three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin list prices that resulted in patients paying more for the medications.
The U.S. Federal Trade Commission said on Friday it was suing the country's three largest pharmacy benefit managers, accusing them of abusing their power and rigging the pharmaceutical supply chain to ...
Axios Vitals on MSN4d
Express Scripts sues FTC over report about pharmacy benefit managersCigna's Express Scripts filed a lawsuit Tuesday challenging a federal report that places the blame for rising drug prices on ...
Cigna Group’s Express Scripts sued the US Federal Trade Commission over a recent report that the company said demonizes ...
(AP) — The federal government is suing some big pharmacy benefit managers, or PBMs ... engaged in anticompetitive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback